Order Article Reprints

Metallinou D, Karampas G, Pavlou M-L, Louma M-I, Mantzou A, Sarantaki A, Nanou C, Gourounti K, Tzeli M, Pantelaki N, et al. Serum Neuron-Specific Enolase as a Biomarker of Neonatal Brain Injury—New Perspectives for the Identification of Preterm Neonates at High Risk for Severe Intraventricular Hemorrhage. Biomolecules. 2024; 14(4):434. https://doi.org/10.3390/biom14040434

Metallinou, Dimitra, Grigorios Karampas, Maria-Loukia Pavlou, Maria-Ioanna Louma, Aimilia Mantzou, Antigoni Sarantaki, Christina Nanou, Kleanthi Gourounti, Maria Tzeli, Nikoletta Pantelaki, and et al. 2024. "Serum Neuron-Specific Enolase as a Biomarker of Neonatal Brain Injury—New Perspectives for the Identification of Preterm Neonates at High Risk for Severe Intraventricular Hemorrhage" Biomolecules 14, no. 4: 434. https://doi.org/10.3390/biom14040434

Metallinou, D., Karampas, G., Pavlou, M.-L., Louma, M.-I., Mantzou, A., Sarantaki, A., Nanou, C., Gourounti, K., Tzeli, M., Pantelaki, N., Tzamakos, E., Boutsikou, T., Lykeridou, A., & Iacovidou, N. (2024). Serum Neuron-Specific Enolase as a Biomarker of Neonatal Brain Injury—New Perspectives for the Identification of Preterm Neonates at High Risk for Severe Intraventricular Hemorrhage. Biomolecules, 14(4), 434. https://doi.org/10.3390/biom14040434